Abacus Medicine to acquire Retail and Hospital business of Riverside Capital-backed A.forall.

Abacus Medicine, a healthcare group that improves access to medicines and invests in innovative pharmaceutical solutions, agreed to acquire Retail and Hospital business of Riverside Capital-backed A.forall, a pharmaceutical company focused on making affordable medicines. Financial terms were not disclosed. “The R&H business unit of A.forall and Abacus Medicine are a perfect match, and we see a great opportunity in combining two businesses that complement each other well. The R&H division of A.forall has strong, direct relationships with pharmacies, whereas Abacus Medicine primarily serves the pharmacies in Belgium via wholesalers. In addition, Abacus Medicine has a strong focus on high-priced medicine, whereas the R&H division has a broad range of lower-priced medicine. By joining forces, we can offer our customers great service and access to a broad and attractive product portfolio," Frederik Heupel, Abacus Medicine Chief Commercial Officer.